(Q34191377)

31 July 2017

1 reference

title

Bloodless medicine: clinical care without allogeneic blood transfusion (English)

1 reference

https://api.crossref.org/works/10.1046/J.1537-2995.2003.00367.X

25 December 2023

1 reference

https://api.crossref.org/works/10.1046/J.1537-2995.2003.00367.X

25 December 2023

author name string

Aryeh Shander

2

1 reference

31 July 2017

Richard Spence

3

1 reference

31 July 2017

Lawrence T. Goodnough

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12702192

25 December 2023

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=12702192

25 December 2023

publication date

1 May 2003

1 reference

full work available at URL

31 July 2017

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1046%2Fj.1537-2995.2003.00367.x

1 reference

https://api.crossref.org/works/10.1046/J.1537-2995.2003.00367.X

https://onlinelibrary.wiley.com/doi/pdf/10.1046/j.1537-2995.2003.00367.x

25 December 2023

1 reference

https://api.crossref.org/works/10.1046/J.1537-2995.2003.00367.X

25 December 2023

1 reference

31 July 2017

volume

43

1 reference

31 July 2017

issue

5

1 reference

31 July 2017

page(s)

668-676

1 reference

Transfusion medicine: looking to the future

31 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2003.00367.X

Autoantibody formation in the alloimmunized red blood cell recipient: clinical and laboratory implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2003.00367.X

A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. Transfusion Requirements in Critical Care Investigators, Canadian Critical Care Trials Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2003.00367.X

Mortality and morbidity in patients with very low postoperative Hb levels who decline blood transfusion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2003.00367.X

Utilization of technologies to reduce allogeneic blood transfusion in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2003.00367.X

21 January 2018

Erythropoietin therapy

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2003.00367.X

Current prevalence and incidence of infectious disease markers and estimated window-period risk in the American Red Cross blood donor population

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2003.00367.X

Transfusion medicine. First of two parts--blood transfusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2003.00367.X

Eliminating blood transfusions: new aspects and perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2003.00367.X

Comprehensive multimodality blood conservation: 100 consecutive CABG operations without transfusion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2003.00367.X

Transfusion medicine. Second of two parts--blood conservation

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2003.00367.X

Preoperative autologous donation decreases allogeneic transfusion but increases exposure to all red blood cell transfusion: results of a meta-analysis. International Study of Perioperative Transfusion (ISPOT) Investigators.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2003.00367.X

Staged physiologic restoration and damage control surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2003.00367.X

Effectiveness of acute normovolemic hemodilution to minimize allogeneic blood transfusion in major liver resections.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2003.00367.X

Infected and malignant fields are an absolute contraindication to intraoperative cell salvage: fact or fiction?

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2003.00367.X

Intraoperative cell salvage in radical retropubic prostatectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2003.00367.X

Progress in the development of RBC substitutes

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2003.00367.X

The effects of increased doses of bovine hemoglobin on hemodynamics and oxygen transport in patients undergoing preoperative hemodilution for elective abdominal aortic surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2003.00367.X

Use of Oxygent, a perfluorochemical-based oxygen carrier, as an alternative to intraoperative blood transfusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2003.00367.X

Perflubron emulsion delays blood transfusions in orthopedic surgery. European Perflubron Emulsion Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2003.00367.X

The value of oxygen-carrying solutions in the operative setting, as determined by mathematical modeling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2003.00367.X

Investigations of West Nile virus infections in recipients of blood transfusions.

21 January 2018

9

1 reference

https://api.crossref.org/works/10.1046/J.1537-2995.2003.00367.X

Human error: the persisting risk of blood transfusion: a report of five cases

25 December 2023

11

1 reference

https://api.crossref.org/works/10.1046/J.1537-2995.2003.00367.X

A standardized multidisciplinary approach reduces the use of allogeneic blood products in patients undergoing cardiac surgery.

25 December 2023

13

1 reference

https://api.crossref.org/works/10.1046/J.1537-2995.2003.00367.X

Total hip replacement surgery without blood transfusion in Jehovah's Witnesses

25 December 2023

14

1 reference

https://api.crossref.org/works/10.1046/J.1537-2995.2003.00367.X

Phlebotomy for diagnostic laboratory tests in adults. Pattern of use and effect on transfusion requirements

25 December 2023

16

1 reference

https://api.crossref.org/works/10.1046/J.1537-2995.2003.00367.X

The rise and fall of preoperative autologous blood donation

25 December 2023

17

1 reference

https://api.crossref.org/works/10.1046/J.1537-2995.2003.00367.X

Declining value of preoperative autologous donation

25 December 2023

19

1 reference

https://api.crossref.org/works/10.1046/J.1537-2995.2003.00367.X

A comparison of two surgical techniques for performing mastectomy

25 December 2023

21

1 reference

https://api.crossref.org/works/10.1046/J.1537-2995.2003.00367.X

Reducing operative blood loss during hepatic surgery: from the middle ages to the space age

25 December 2023

22

1 reference

https://api.crossref.org/works/10.1046/J.1537-2995.2003.00367.X

25 December 2023

Transfusion and surgery

26

1 reference

https://api.crossref.org/works/10.1046/J.1537-2995.2003.00367.X

The effects of red-cell scavenging, hemodilution, and active warming on allogenic blood requirements in patients undergoing hip or knee arthroplasty.

25 December 2023

29

1 reference

https://api.crossref.org/works/10.1046/J.1537-2995.2003.00367.X

Acute normovolemic hemodilution should replace the preoperative donation of autologous blood as a method of autologous-blood procurement

25 December 2023

30

1 reference

https://api.crossref.org/works/10.1046/J.1537-2995.2003.00367.X

Acute normovolemic hemodilution is a cost‐effective alternative to preoperative autologous blood donation by patients undergoing radical retropubic prostatectomy

25 December 2023

32

1 reference

https://api.crossref.org/works/10.1046/J.1537-2995.2003.00367.X

The safety of intraoperative autologous blood collection and autotransfusion during cesarean section

25 December 2023

34

1 reference

https://api.crossref.org/works/10.1046/J.1537-2995.2003.00367.X

Amniotic fluid removal during cell salvage in the cesarean section patient

25 December 2023

35

1 reference

https://api.crossref.org/works/10.1046/J.1537-2995.2003.00367.X

The impact of intraoperative autologous blood transfusion during type III radical hysterectomy for early-stage cervical cancer

25 December 2023

37

1 reference

https://api.crossref.org/works/10.1046/J.1537-2995.2003.00367.X

Blood irradiation for intraoperative autotransfusion in cancer surgery: demonstration of efficient elimination of contaminating tumor cells

25 December 2023

38

1 reference

https://api.crossref.org/works/10.1046/J.1537-2995.2003.00367.X

Intraoperative salvage in patients undergoing elective abdominal aortic aneurysm repair: an analysis of cost and benefit

25 December 2023

40

1 reference

https://api.crossref.org/works/10.1046/J.1537-2995.2003.00367.X

Is a low transfusion threshold safe in critically ill patients with cardiovascular diseases?

25 December 2023

41

1 reference

https://api.crossref.org/works/10.1046/J.1537-2995.2003.00367.X

Preoperative red cell production in patients undergoing aggressive autologous blood phlebotomy with and without erythropoietin therapy

25 December 2023

44

1 reference

https://api.crossref.org/works/10.1046/J.1537-2995.2003.00367.X

Erythropoiesis in patients stimulated with erythropoietin: the relevance of storage iron

25 December 2023

47

1 reference

https://api.crossref.org/works/10.1046/J.1537-2995.2003.00367.X

Erythropoietin response to anaemia is not altered by surgery or recombinant human erythropoietin therapy

25 December 2023

48

1 reference

https://api.crossref.org/works/10.1046/J.1537-2995.2003.00367.X

Rate of blood regeneration after blood loss

25 December 2023

49

1 reference

https://api.crossref.org/works/10.1046/J.1537-2995.2003.00367.X

Treatment of haemochromatosis by energetic phlebotomy; one patient's response to the letting of 55 litres of blood in 11 months

25 December 2023

50

1 reference

https://api.crossref.org/works/10.1046/J.1537-2995.2003.00367.X

Evidence-based recommendations for the clinical use of recombinant human erythropoietin

25 December 2023

53

1 reference

https://api.crossref.org/works/10.1046/J.1537-2995.2003.00367.X

Evaluation of tolerance of and response to iron dextran (Imferon) administered by total dose infusion to pregnant women with iron deficiency anemia

25 December 2023

54

1 reference

https://api.crossref.org/works/10.1046/J.1537-2995.2003.00367.X

Control of marrow production by the level of iron supply

25 December 2023

56

1 reference

https://api.crossref.org/works/10.1046/J.1537-2995.2003.00367.X

Blood substitutes — a moving target

25 December 2023

58

1 reference

https://api.crossref.org/works/10.1046/J.1537-2995.2003.00367.X

Hemoglobin and methemoglobin concentrations after large-dose infusions of diaspirin cross-linked hemoglobin

25 December 2023

62

1 reference

https://api.crossref.org/works/10.1046/J.1537-2995.2003.00367.X

Recombinant Human Hemoglobin (rHb1.1) Selectively Inhibits Vasorelaxation Elicited by Nitric Oxide Donors in Rabbit Isolated Aortic Rings

25 December 2023

63

1 reference

https://api.crossref.org/works/10.1046/J.1537-2995.2003.00367.X

25 December 2023

Blood substitutes

64

1 reference

https://api.crossref.org/works/10.1046/J.1537-2995.2003.00367.X

Diaspirin cross-linked hemoglobin (DCLHb) in the treatment of severe traumatic hemorrhagic shock: a randomized controlled efficacy trial

25 December 2023

66

1 reference

https://api.crossref.org/works/10.1046/J.1537-2995.2003.00367.X

Red blood cell substitutes: current status

25 December 2023

69

1 reference

https://api.crossref.org/works/10.1046/J.1537-2995.2003.00367.X

Bioartificial organ support for hepatic, renal, and hematologic failure

25 December 2023

70

1 reference

https://api.crossref.org/works/10.1046/J.1537-2995.2003.00367.X

Cardiovascular and coronary physiology of acute isovolemic hemodilution: a review of nonoxygen-carrying and oxygen-carrying solutions

25 December 2023

71

1 reference

https://api.crossref.org/works/10.1046/J.1537-2995.2003.00367.X

Blood substitute and erythropoietin therapy in a severely injured Jehovah's witness

25 December 2023

72

1 reference

https://api.crossref.org/works/10.1046/J.1537-2995.2003.00367.X

Transfusions of polymerized bovine hemoglobin in a patient with severe autoimmune hemolytic anemia

25 December 2023

74

1 reference

https://api.crossref.org/works/10.1046/J.1537-2995.2003.00367.X

The prospects for red-cell substitutes

25 December 2023

75

1 reference

https://api.crossref.org/works/10.1046/J.1537-2995.2003.00367.X

Transfusion of polymerised human haemoglobin in a patient with severe sickle-cell anaemia

25 December 2023

76

1 reference

https://api.crossref.org/works/10.1046/J.1537-2995.2003.00367.X

Cell-free hemoglobin limits nitric oxide bioavailability in sickle-cell disease

25 December 2023

77

1 reference

https://api.crossref.org/works/10.1046/J.1537-2995.2003.00367.X

25 December 2023

Identifiers

1 reference

31 July 2017

1 reference